David Dobrzynski
Impact in
-
- Antibiotic Use and Resistance
-
- Antibiotic Resistance in Bacteria
Papers in
-
- Influenza Virus Research Studies 2
-
- SARS-CoV-2 and COVID-19 Research 1
- Co-authors
- Danielle Ndi (1 shared paper)H. Keipp Talbot (1 shared paper)Tiffanie Markus (1 shared paper)Yuwei Zhu (1 shared paper)William Schaffner (1 shared paper)Dilek İnce (1 shared paper)Howard S. Gold (1 shared paper)Sara E. Cosgrove (2 shared papers)
- Journals
- The Journal of Infectious Diseases (2 papers)Open Forum Infectious Diseases (1 paper)Clinical Transplantation (1 paper)Annals of Pharmacotherapy (1 paper)Journal of Pharmacy Practice (1 paper)
- Partner nations
- United States
In The Last Decade
David Dobrzynski
6 papers receiving 55 citations
Peers
Comparison fields: 5 of 23
- Applied Microbiology and Biotechnology 25
- Molecular Medicine 13
- Clinical Biochemistry 8
- Critical Care and Intensive Care Medicine 5
- Infectious Diseases 13
Countries citing papers authored by David Dobrzynski
This map shows the geographic impact of David Dobrzynski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Dobrzynski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Dobrzynski more than expected).
Fields of papers citing papers by David Dobrzynski
This network shows the impact of papers produced by David Dobrzynski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Dobrzynski. The network helps show where David Dobrzynski may publish in the future.
Co-authors
The 21 scholars most cited alongside David Dobrzynski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 20 | |
| 2 | 2023 | 17 | |
| 3 | 2020 | 13 | |
| 4 | 2024 | 2 | |
| 5 | 2022 | 2 | |
| 6 | 2025 | 1 |
About David Dobrzynski
David Dobrzynski is a scholar working on Epidemiology, Infectious Diseases, Health, Molecular Medicine and Applied Microbiology and Biotechnology, having authored 6 papers that have together received 55 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (2 papers), Vaccine Coverage and Hesitancy (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), Antibiotic Use and Resistance (1 paper) and Antibiotic Resistance in Bacteria (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (25 citations), Molecular Medicine (13 citations), Clinical Biochemistry (8 citations), Critical Care and Intensive Care Medicine (5 citations) and Infectious Diseases (13 citations). David Dobrzynski has collaborated with scholars based in United States. Frequent co-authors include Danielle Ndi, H. Keipp Talbot, Tiffanie Markus, Yuwei Zhu, William Schaffner, Dilek İnce, Howard S. Gold, Sara E. Cosgrove, Angela R Branche and Pranita D. Tamma. Their work appears in journals such as The Journal of Infectious Diseases, Open Forum Infectious Diseases, Clinical Transplantation, Annals of Pharmacotherapy and Journal of Pharmacy Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.